Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Influenza Nucleoprotein Produkte

(Influenza Nucleoprotein (NP))
Encapsidates the negative strand viral RNA, protecting it from nucleases. The encapsidated genomic RNA is termed the ribonucleoprotein (RNP) and serves as template for transcription and replication. The RNP needs to be localized in the nucleus to start an infectious cycle, but is too large to diffuse through the nuclear pore complex. NP comprises at least 2 nuclear localization signals and is responsible of the active RNP import into the nucleus through the cellular importin alpha/beta pathway. Later in the infection, nucleus export of RNP are mediated through viral proteins NEP interacting with M1 which binds nucleoproteins. It is possible that the nucleoprotein binds directly exportin-1 (XPO1) and plays an active role in RNP nuclear export. M1 interaction with RNP seems to hide nucleoprotein's nuclear localization signals. Soon after a virion infects a new cell, M1 dissociates from the RNP under acidification of the virion driven by M2 protein. Dissociation of M1 from RNP unmask nucleoprotein's nuclear localization signals, targeting the RNP to the nucleus (By similarity).

antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.

Ausgewählte Influenza Nucleoprotein Kategorien

Influenza Nucleoprotein Antikörper

High quality antibodies with extensive validation data.

Influenza Nucleoprotein Proteine

Proteins for various applications incl. WB, ELISA, IF etc.

Empfohlene Influenza Nucleoprotein Antikörper

Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität Influenza A Virus H2N2
Applikation ELISA, WB, IF, IHC, IP, IC
Validierungen
  • (3)
  • (4)
Kat. Nr. ABIN2452039
Menge 100 μg
Datenblatt Datenblatt
Reaktivität Influenza A Virus H2N2
Applikation ELISA, WB, IHC, IC
Validierungen
  • (3)
  • (3)
Kat. Nr. ABIN2452038
Menge 50 μg
Datenblatt Datenblatt
Reaktivität Influenza B Virus
Applikation ELISA
Validierungen
  • (1)
  • (1)
Kat. Nr. ABIN5707182
Menge 1 mL
Datenblatt Datenblatt

Empfohlene Influenza Nucleoprotein Proteine

Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität Influenza B Virus
Source HEK-293 Cells
Validierungen
Kat. Nr. ABIN7385956
Menge 1 mg
Datenblatt Datenblatt
Reaktivität Influenza A Virus
Source HEK-293 Cells
Validierungen
Kat. Nr. ABIN7385954
Menge 1 mg
Datenblatt Datenblatt
Reaktivität Influenza A Virus
Source Escherichia coli (E. coli)
Validierungen
Kat. Nr. ABIN7519580
Menge 1 mg
Datenblatt Datenblatt

Neueste Publikationen zu unseren Influenza Nucleoprotein Produkten

Hao, Wang, Li: "FKBP5 Regulates RIG-I-Mediated NF-κB Activation and Influenza A Virus Infection." in: Viruses, Vol. 12, Issue 6, (2020) (PubMed).

Hong, Song, Kim, Cho, Jeong, Yang, Jeong, Ahn, Jeong, Kim, Chang, Ko: "Morin Hydrate Inhibits Influenza Virus entry into Host Cells and Has Anti-inflammatory Effect in Influenza-infected Mice." in: Immune network, Vol. 20, Issue 4, pp. e32, (2020) (PubMed).

Gogoi, Mansouri, Katikaneni, Jin: "New MoDC-Targeting TNF Fusion Proteins Enhance Cyclic Di-GMP Vaccine Adjuvanticity in Middle-Aged and Aged Mice." in: Frontiers in immunology, Vol. 11, pp. 1674, (2020) (PubMed).

Mansouri, Katikaneni, Gogoi, Pipkin, Machuca, Emtiazjoo, Jin: "Lung IFNAR1hi TNFR2+ cDC2 promotes lung regulatory T cells induction and maintains lung mucosal tolerance at steady state." in: Mucosal immunology, Vol. 13, Issue 4, pp. 595-608, (2020) (PubMed).

Tan, Esterbauer, Vanderven, Juno, Kent, Wheatley: "Inducible Bronchus-Associated Lymphoid Tissues (iBALT) Serve as Sites of B Cell Selection and Maturation Following Influenza Infection in Mice." in: Frontiers in immunology, Vol. 10, pp. 611, (2020) (PubMed).

Zhao, Sridharan, Chen, Baker, Wang, Krug: "Influenza B virus non-structural protein 1 counteracts ISG15 antiviral activity by sequestering ISGylated viral proteins." in: Nature communications, Vol. 7, pp. 12754, (2018) (PubMed).

Kamal, Blanchfield, Belser, Music, Tzeng, Holiday, Burroughs, Sun, Maines, Levine, York: "Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies." in: Journal of virology, Vol. 91, Issue 20, (2017) (PubMed).

Bose, McCaul, Mei, Sasman, He, Kramp, Shively, Yan, Henrickson: "Simulated Respiratory Secretion for Use in the Development of Influenza Diagnostic Assays." in: PLoS ONE, Vol. 11, Issue 11, pp. e0166800, (2017) (PubMed).

Belardo, Cenciarelli, La Frazia, Rossignol, Santoro: "Synergistic effect of nitazoxanide with neuraminidase inhibitors against influenza A viruses in vitro." in: Antimicrobial agents and chemotherapy, Vol. 59, Issue 2, pp. 1061-9, (2015) (PubMed).

Kim, Kim, Lee, Chu, Kang, Kim, Lee: "Pathogenesis of novel reassortant avian influenza virus A (H5N8) Isolates in the ferret." in: Virology, Vol. 481, pp. 136-41, (2015) (PubMed).

Synonyme und alternative Namen zu Influenza Nucleoprotein

nucleoprotein (NP)
Sie sind hier:
Kundenservice